Proadrenomedullin: An effective prognostic biomarker in septic patients
- Cortés, M.
- Mayor, M.
- García-Torre, A.
- Castro-Vega, I.
- Enguix-Armada, A.
Publication date
July 2014
DOI Publisher
De Gruyter Journal
Clinical Chemistry and Laboratory Medicine (CCLM)Abstract
Meeting abstractBackground: Measurement of biomarkers is a potential approach to early prediction of mortality in septic patients. The purpose of this study was to asses the prognostic value of proadrenomedullin (pADM) in adult patients with sepsis with a single measurement in the first 24 hours after the onset of severe sepsis or septic shock. Conclusions: The protein pADM is an important prognostic biomarker of survival when measured on admission of septic patients to the ICU.Ye
Add to ORKG